These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 34981814)

  • 41. Mining human antibody repertoires.
    Beerli RR; Rader C
    MAbs; 2010; 2(4):365-78. PubMed ID: 20505349
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Engineering and characterization of a chimeric anti-platelet glycoprotein Ibalpha monoclonal antibody and preparation of its Fab fragment.
    Yang J; Ji S; Dong N; Zhao Y; Ruan C
    Hybridoma (Larchmt); 2010 Apr; 29(2):125-32. PubMed ID: 20443704
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Preparation and characterization of a new monoclonal antibody against CXCR4 using lentivirus vector.
    Li X; Kuang Y; Huang X; Zou L; Huang L; Yang T; Li W; Yang Y
    Int Immunopharmacol; 2016 Jul; 36():100-105. PubMed ID: 27124560
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Advances in tumour immunotherapy.
    King J; Waxman J; Stauss H
    QJM; 2008 Sep; 101(9):675-83. PubMed ID: 18477644
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Role of monoclonal antibody therapy in the treatment of infectious disease.
    Chmel H
    Am J Hosp Pharm; 1990 Nov; 47(11 Suppl 3):S11-5. PubMed ID: 2275476
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Recombinant single-chain variable fragment antibodies directed against Clostridium difficile toxin B produced by use of an optimized phage display system.
    Deng XK; Nesbit LA; Morrow KJ
    Clin Diagn Lab Immunol; 2003 Jul; 10(4):587-95. PubMed ID: 12853390
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bispecific antibodies for viral immunotherapy.
    Nyakatura EK; Soare AY; Lai JR
    Hum Vaccin Immunother; 2017 Apr; 13(4):836-842. PubMed ID: 27786606
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Phage display screening of TIGIT-specific antibody for antitumor immunotherapy.
    Li D; Hu S; Fan Q; Bao W; Zhou W; Xu T; Ye T; Liu H; Song L
    Biosci Biotechnol Biochem; 2019 Sep; 83(9):1683-1696. PubMed ID: 31094670
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antibody-based immunotherapy of solid cancers: progress and possibilities.
    Nicodemus CF
    Immunotherapy; 2015; 7(8):923-39. PubMed ID: 26314410
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Monoclonal antibodies in cancer immunotherapy.
    Kimiz-Gebologlu I; Gulce-Iz S; Biray-Avci C
    Mol Biol Rep; 2018 Dec; 45(6):2935-2940. PubMed ID: 30311129
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Phage display derived therapeutic antibodies.
    Thie H; Meyer T; Schirrmann T; Hust M; Dübel S
    Curr Pharm Biotechnol; 2008 Dec; 9(6):439-46. PubMed ID: 19075684
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Preparation and characterization of a novel chimeric antibody against human CD40 with the potential to inhibit Daudi cell proliferation.
    Qu QX; Ge Y; Chen YJ; Chen C; Qiu YH; Zhang XG
    Hybridoma (Larchmt); 2009 Apr; 28(2):121-8. PubMed ID: 19382845
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Next-Generation Techniques for Discovering Human Monoclonal Antibodies].
    Lushova AA; Biazrova MG; Prilipov AG; Sadykova GK; Kopylov TA; Filatov AV
    Mol Biol (Mosk); 2017; 51(6):899-906. PubMed ID: 29271955
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Production, novel assay development and clinical applications of monoclonal antibodies.
    Chiarella P
    Recent Pat Anticancer Drug Discov; 2011 May; 6(2):258-67. PubMed ID: 21247405
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Avelumab: is it time to get excited?
    Marciscano AE; Gulley JL; Kaufman HL
    Expert Rev Anticancer Ther; 2018 Sep; 18(9):815-821. PubMed ID: 29939083
    [No Abstract]   [Full Text] [Related]  

  • 56. Genetically engineered monoclonal antibodies for direct anti-neoplastic treatment and cancer cell specific delivery of chemotherapeutic agents.
    Bodey B; Bodey B; Siegel SE; Kaiser HE
    Curr Pharm Des; 2000 Feb; 6(3):261-76. PubMed ID: 10637379
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immunotargeting and therapy of cancer by advanced multivalence antibody scaffolds.
    Kafil V; Saei AA; Tohidkia MR; Barar J; Omidi Y
    J Drug Target; 2020 Dec; 28(10):1018-1033. PubMed ID: 32434407
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A simple methodology for conversion of mouse monoclonal antibody to human-mouse chimeric form.
    Dang VT; Mandakhalikar KD; Ng OW; Tan YJ
    Clin Dev Immunol; 2013; 2013():716961. PubMed ID: 24078817
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Monoclonal antibodies in urology.
    Moon TD; Vessella RL; Lange PH
    J Urol; 1983 Sep; 130(3):584-92. PubMed ID: 6350618
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Monoclonal antibody for cancer treatment].
    Achiwa H; Sato S; Ueda R
    Gan To Kagaku Ryoho; 2002 Apr; 29(4):495-501. PubMed ID: 11977531
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.